You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metformin 1000 mg Prolonged Release Tablets

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pharmacokinetics Trial in Prague (Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine), Glucophage® XR 1000 mg

Completed
  • Pharmacokinetics
  • Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine)
  • Glucophage® XR 1000 mg Prolonged Release Tablets
  • Prague, Czechia
    QUINTA-ANALYTICA s.r.o.
Nov 17, 2021

Pharmacokinetics Trial in Prague (Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine), Glucophage® XR 1000 mg

Completed
  • Pharmacokinetics
  • Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine)
  • Glucophage® XR 1000 mg Prolonged Release Tablets (Merck Serono Ltd, UK)
  • Prague, Czechia
    QUINTA-ANALYTICA s.r.o.
Nov 9, 2021

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Fed Conditions Trial in Tunis (Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg) (Galvumet®), Metformin /

Completed
  • Fed Conditions
  • Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg) (Galvumet®)
  • Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg)
  • Tunis, Tunisia
    Centre National Chalbi Belkahia de Pharmacovogilance
Oct 13, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza Garcia (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza Garcia, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Pharmacokinetics Trial in Prague (Metformin 500mg prolonged release tablets (JSC Farmak, Ukraine), Glucophage® XR 500 mg

Completed
  • Pharmacokinetics
  • Metformin 500mg prolonged release tablets (JSC Farmak, Ukraine)
  • Glucophage® XR 500 mg prolonged release tablets (Merck Serono Ltd, UK)
  • Prague, Czechia
    QUINTA-ANALYTICA s.r.o.
Nov 17, 2021

Healthy Trial in Cairo (Gleptomet 50/1000(Metformin HCl & Sitagliptin), Janumet 50/1000(Metformin HCl & Sitagliptin))

Completed
  • Healthy
  • Gleptomet 50/1000(Metformin HCl & Sitagliptin)
  • Janumet 50/1000(Metformin HCl & Sitagliptin)
  • Cairo, Egypt
    Genuine Research Center GRC
Mar 22, 2023

Healthy Trial in Cairo (Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose), Mirfenacin MR

Completed
  • Healthy
  • Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose)
  • +2 more
  • Cairo, Egypt
    Genuine Research Center GRC
Mar 2, 2023

Pharmacokinetics Trial in Prague (Metformin, prolonged-release tablets 500 mg (JSC Farmak, Ukraine), Glucophage® XR 500 mg

Completed
  • Pharmacokinetics
  • Metformin, prolonged-release tablets 500 mg (JSC Farmak, Ukraine)
  • Glucophage® XR 500 mg prolonged release tablets (Merck Serono Ltd, UK)
  • Prague, Czechia
    QUINTA-ANALYTICA s.r.o.
Nov 17, 2021

Bioequivalence, Type 2 Diabetes Trial in Mount Royal (Sitagliptin/metformin HCl (HCl) 50/1000 mg film-coated tablet)

Completed
  • Bioequivalence
  • Type 2 Diabetes
  • Sitagliptin/metformin hydrochloride (HCl) 50/1000 mg film-coated tablet
  • Mount Royal, Quebec, Canada
    Algorithme Pharma
Sep 20, 2022

Preeclampsia Trial in Sweden (Metformin ER, Placebo)

Not yet recruiting
  • Preeclampsia
  • Metformin ER
  • Placebo
  • Falun, Sweden
  • +5 more
Sep 10, 2023

Knee Osteoarthritis, Metformin Trial in Dhaka (Metformin 500 Mg extended release Oral Tablet, Placebo oral tablet)

Recruiting
  • Knee Osteoarthritis
  • Metformin
  • Metformin 500 Mg extended release Oral Tablet
  • Placebo oral tablet
  • Dhaka, Bangladesh
    Bangabandhu Sheikh Mujib Medical University
Nov 13, 2023

To Determine Bioequivalence Under Fed Conditions Trial (Metformin and Vildagliptin 1000/50 mg)

Completed
  • To Determine Bioequivalence Under Fed Conditions
  • Metformin and Vildagliptin 1000/50 mg
  • (no location specified)
Apr 14, 2022

Type 2 Diabetes Trial in Nakhon Pathom (Gemigliptin tartrate sesquihydrate and metformin, gemigliptin 50 mg and metformin HCl

Completed
  • Type 2 Diabetes
  • Gemigliptin tartrate sesquihydrate and metformin
  • gemigliptin 50 mg and metformin hydrochloride 1000 mg prolonged release
  • Nakhon Pathom, Thailand
    International Bio Service Co., Ltd.
Feb 4, 2021

Healthy Trial in Arzo (Trazodone HCl - new polymer, Trazodone HCl - Contramid®)

Completed
  • Healthy
  • Trazodone HCl - new polymer
  • Trazodone HCl - Contramid®
  • Arzo, Switzerland
    CROSS Research S.A., Phase I Unit, Via F.A. Giorgioli 14 Phone:
Nov 15, 2021

Type2diabetes Trial in Nasiriyah, Basrah (Insulin Glargine 100 UNT/ML Pen Injector [Lantus], Saxagliptin 2.5 mg/ Metformin

Not yet recruiting
  • Type2diabetes
  • Insulin Glargine 100 UNT/ML Pen Injector [Lantus]
  • +2 more
  • Nasiriyah, Thi Qar, Iraq
  • +1 more
Oct 28, 2023

Iron Overload Due to Repeated Red Blood Cell Transfusions Trial in Worldwide (Deferiprone DR tablets 1000 mg (Low dosage),

Completed
Has Results
  • Iron Overload Due to Repeated Red Blood Cell Transfusions
  • Deferiprone DR tablets 1000 mg (Low dosage)
  • Deferiprone DR tablets 1000 mg (High dosage)
  • Chicago, Illinois
  • +4 more
Jun 17, 2021

Diabetes, Type 2 Trial in Worldwide (Semaglutide, Empagliflozin, Metformin)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Toluca Lake, California
  • +101 more
Oct 9, 2023

Lower Urinary Tract Symptoms, Voiding Disorders, Pain Trial in Split (Tadalafil 5mg, Tamsulosin Hydrochloride 400 Microgram

Enrolling by invitation
  • Lower Urinary Tract Symptoms
  • +3 more
  • Tadalafil 5mg
  • +2 more
  • Split, Splitsko-dalmatinska, Croatia
    University hospital of Splity
Sep 11, 2022

Healthy Trial in Jeonju (Janumet XR tablet 100/1000 mg, GLH1SM tablet 100/1000 mg)

Completed
  • Healthy
  • Janumet XR tablet 100/1000 mg
  • GLH1SM tablet 100/1000 mg
  • Jeonju, Jeollabuk-do, Korea, Republic of
    Chonbuk National University Hospital
Jul 21, 2020

Fed Conditions Trial in Bab Souika (Metformin / Vildagliptin Film Coated Tablets (850 mg / 50 mg), Galvumet® Film Coated Tablets

Completed
  • Fed Conditions
  • Metformin / Vildagliptin Film Coated Tablets (850 mg / 50 mg)
  • Galvumet® Film Coated Tablets (850 mg / 50 mg)
  • Bab Souika, Tunise, Tunisia
    Centre National Chalbi Belkahia de Pharmacovogilance
Oct 22, 2023

Drug Use Trial in Jakarta Pusat (Metformin Hydrochloride 500 MG)

Completed
  • Drug Use
  • Metformin Hydrochloride 500 MG
  • Jakarta Pusat, DKI Jakarta, Indonesia
    PT Pharma Metric Labs
Feb 21, 2023

Type 2 Diabetes Trial (hrx0701 tablets?Metformin HCl tablets?Retagliptin phosphate tablets, hrx0701 tablets)

Completed
  • Type 2 Diabetes Mellitus
  • hrx0701 tablets、Metformin hydrochloride tablets、Retagliptin phosphate tablets
  • hrx0701 tablets
  • Changsha, Hunan, China
    Xiangya Third Hospital
Dec 20, 2022